NEW YORK--(BUSINESS WIRE)--Dec. 19, 2005--Callisto Pharmaceuticals, Inc. (AMEX:KAL)(FWB:CA4), a developer of new drug treatments in the fight against cancer and other major health threats, has reported significant progress on several major fronts in its year-end corporate review of key business achievements for 2005.
